The CCL2 ELISA data showed that plasma levels of CCL2 were significantly increased in the entire BC group compared to the total control group (benign breast tumor and healthy subjects) (p<0.001), similarly as the median levels of CA 15-3 (p<0.001). The gene discussed is CCL2; the disease is breast cancer.